Related references
Note: Only part of the references are listed.The Genomic Ancestry of Individuals from Different Geographical Regions of Brazil Is More Uniform Than Expected
Sergio D. J. Pena et al.
PLOS ONE (2011)
Pharmacogenetics of Membrane Transporters: An Update on Current Approaches
Tristan M. Sissung et al.
MOLECULAR BIOTECHNOLOGY (2010)
VKORC1 polymorphisms in Brazilians: comparison with the Portuguese and Portuguese-speaking Africans and pharmacogenetic implications
Guilherme Suarez-Kurtz et al.
PHARMACOGENOMICS (2010)
Linkage Disequilibrium Patterns and Genetic Structure of Amerindian and Non-Amerindian Brazilian Populations Revealed by Long-Range X-STR Markers
Fabio P. N. Leite et al.
AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY (2009)
A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function
King Leung Fung et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2009)
Y-STR analysis in Brazilian and south Amerindian Populations
Fabio P. N. Leite et al.
AMERICAN JOURNAL OF HUMAN BIOLOGY (2008)
Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability
Uros Potocnik et al.
CANCER GENETICS AND CYTOGENETICS (2008)
Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in Caucasian patients with androgen-independent prostatic cancer
Akinobu Hamada et al.
CLINICAL CANCER RESEARCH (2008)
Influence of SLCO1B3 Gene Polymorphism on the Pharmacokinetics of Digoxin in Terminal Renal Failure
Masayuki Tsujimoto et al.
DRUG METABOLISM AND PHARMACOKINETICS (2008)
Distribution of ABCB1 polymorphisms among Brazilians: impact of population admixture
Rita C. E. Estrela et al.
PHARMACOGENOMICS (2008)
Global analysis of genetic variation in SLCOIB1
Marja K. Pasanen et al.
PHARMACOGENOMICS (2008)
ABC multidrug transporters: structure, function and role in chemoresistance
Frances J. Sharom
PHARMACOGENOMICS (2008)
Determination of ABCB1 polymorphisms and haplotypes frequencies in a French population
Elise Jeannesson et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2007)
Role of OATP transporters in the disposition of drugs
Mikko Niemi
PHARMACOGENOMICS (2007)
A silent polymorphism in the MDR1 gene changes substrate specificity
Chava Kimchi-Sarfaty et al.
SCIENCE (2007)
Variants in the SLCO1B3 gene: Interethnic distribution and association with paclitaxel pharmacokinetics
N. F. Smith et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Application of an African ancestry index as a genomic control approach in a Brazilian population
V. M. Zembrzuski et al.
ANNALS OF HUMAN GENETICS (2006)
The genetic structure of human populations studied through short insertion-deletion polymorphisms
Luciana Bastos-Rodrigues et al.
ANNALS OF HUMAN GENETICS (2006)
Frequencies of single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide 1B1 SLCO1B1 gene in a Finnish population
Marja K. Pasanen et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Pharmacogenomics of human OATP transporters
J König et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population
AC Allabi et al.
PHARMACOGENETICS AND GENOMICS (2005)
The role of common variants of ABCB1, CYP3A4, and CYP3A5 genes in lipid-lowering efficacy and safety of simvastatin treatment
M Fiegenbaum et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Transporters and drug therapy: Implications for drug disposition and disease
RH Ho et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Organic anion transporting polypeptides of the OATP/SLC21 family:: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties
B Hagenbuch et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2004)
High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)
M Niemi et al.
PHARMACOGENETICS (2004)
Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8)
K Letschert et al.
PHARMACOGENETICS (2004)
A variant 2677A allele of the MDR1 gene affects fexofenadine disposition
SY Yi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Historical genetics: Spatiotemporal analysis of the formation of the Brazilian population
SM Callegari-Jacques et al.
AMERICAN JOURNAL OF HUMAN BIOLOGY (2003)
Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene
DL Kroetz et al.
PHARMACOGENETICS (2003)
Signatures of natural selection in the human genome
M Bamshad et al.
NATURE REVIEWS GENETICS (2003)
Color and genomic ancestry in Brazilians
FC Parra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Expression and localization of P-glycoprotein in human heart:: Effects of cardiomyopathy
K Meissner et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2002)
Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P-glycoprotein
Y Kurata et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Polymorphisms in OATP-C -: Identification of multiple allelic variants associated with altered transport activity among European- and African-Americans
RG Tirona et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Frequency of C3435T polymorphism of MDR1 gene in African people
E Schaeffeler et al.
LANCET (2001)
MDR1 pharmacogenetics:: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity
MM Ameyaw et al.
PHARMACOGENETICS (2001)
Share Paper
